Here are some thoughs on the fact that debenture holders have accepted to get paid in shares at $0.08 even if the price seems to trade around $0.045. I see 3 options:
1) They know that the company is worth alot more than $0.08 and they are going to make money over this decision in the long run.
In the mean time they are probably playing the market to keep the SP down. Knowing that at the date of the deal $600k interest will be paid in shares at market price. That is a whopping 15M shares. By selling 2-3M shares they are easilly able to control the SP until the deal and make a nice quick return.
2) They think the company is worth close to $0.08 and in order to get the financing from Otto Bock through they decided to accept this offer as reasonable and avoid putting VHB in a cash difficult situation which would have also jeopardize their investment.
Again in the mean time they control the SP and make a small extra by getting 15M shares at low price.
3) They knew that Victhom was going down and they decided to accept the deal even if they think VHB is not worth $0.08. However that was better than loosing everything. They will be selling every time the price moves up and have alot to sell
Let me know your thoughs on this. If anybody still follows the SP.
At the end of this process. Midsummer will own 31.35% of VHB and Islandia will own 16.86%. That is almost 50%.
At that point these 2 entities will pretty much control what is going on and I am sure they will have good reasons to put pressure in order to get the SP up. I am not sure of seeing VHB over $0.20 any time soon excluding the consolidation of course. However I have good hopes to see it to $0.10.
Ottobock already has a product similar to the Neurostep, the ActiGait. They know how much that market is worth and they probably know that Victhom's technology is way better and they would have lost all the market to Neurostep.
I still don't understand why Ossur didn't seize this opportunity to beat Otto Bock and try to become #1 worldwide.
GLTA